Clinico-immunological effectiveness of immunotherapy in patients with respiratory syncytial virus infection

Cover Page

Cite item

Full Text

Abstract

We studied 44 patients with different complications of respiratory syncytial virus infection (bronchitis, acute tonsillitis, pneumonia). 29 patients were treated by recombinant interferon-α2b in the form of rectal suppositories (Viferon) as an addition medication to a common therapy. The results of clinical and immunological analysis showed that use of interferon in case of bronchitis or acute tonsillitis may be unreasonable, but it had relative indications in case of pneumonia

About the authors

Y A Klimova

Peoples' Friendship University of Russia

Кафедра инфекционных болезнейс курсом эпидемиологииМедицинский факультет; Российский университет дружбы народов; Peoples' Friendship University of Russia

A K Tokmalaev

Peoples' Friendship University of Russia

Кафедра инфекционных болезнейс курсом эпидемиологииМедицинский факультет; Российский университет дружбы народов; Peoples' Friendship University of Russia

I P Balmasova

NIMSI, Moscow State University of Medicine and Dentistry

Лаборатория патогенеза и методовлечения инфекционных заболеваний; НИМСИ МГМСУ; NIMSI, Moscow State University of Medicine and Dentistry

References


Copyright (c) 2011 Климова Ю.А., Токмалаев А.К., Балмасова И.П.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies